Cambridge Healthtech Institute’s Inaugural

Immuno-Oncology Investing & Partnering Forum

Facilitating Partnering, Funding & Investment to Advance Immuno-Oncology Drugs

August 30, 2018

Cambridge Healthtech Institute is pleased to announce the Inaugural Immuno-Oncology Investing & Partnering Forum to run as part of the Immuno-Oncology Summit in Boston on August 30, 2018. This timely and focused event brings together early- and late-stage investors with fundraising CEOs and research entrepreneurs to encourage partnering and investment, and to ultimately accelerate immune-oncology therapies to market. This Forum will provide ample opportunity for both investors and CEOs to interact through pre-scheduled 1-1 meetings, as well as interactive panels presented by pharma business development and the VC/investment community. Both late-stage and emerging tech companies will present on the agenda.

Cover will include, but is not limited to:

  • Pharmaceuticals
  • Biotechnology
  • Venture Capital Firms
  • Angel Investors
  • Young Companies
  • Emerging Companies – Now accepting submissions!

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is February 9, 2018.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Kaitlyn Barago
Associate Conference Producer
Cambridge Healthtech Institute
Phone: (+1) 781-247-6282

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286